Privacy Policy
We do not collect any personally identifiable information about you unless you provide it to us voluntarily. If you do not want your personally identifiable information to be collected, please do not submit it to us.
If you do provide us with personally identifiable information, such as your name, postal address, e-mail address, telephone numbers, and other personal information, we may contact you, via e-mail or regular mail, to provide you with information we believe may be of interest to you. At the time, you will be offered the opportunity to opt out of this service. We do not sell or transfer to others outside our company the information you send to us, except that your data may be transferred to an outside fulfillment company for processing and mailing purposes only. We consider your
e-mail address and any personal information you give to be private, and these data will be kept confidential within the Bristol-Myers Squibb Sanofi-Synthelabo Partnership and by any outside fulfillment company. Within Bristol-Myers Squibb Sanofi-Synthelabo Partnership, data may be transferred to or accessed by authorized Bristol-Myers Squibb Sanofi-Synthelabo Partnership personnel in other countries. At all times, personal data are treated confidentially.
Data that are not personal, such as questions, comments, ideas, and suggestions, shall be deemed to be nonconfidential, and Bristol-Myers Squibb Sanofi-Synthelabo Partnership shall be free to disclose and use the same, without any obligation whatsoever to you, for any purpose and through any means.
In addition, we may store some information on your computer to improve the quality of your visit to our site. In some cases, this information will help us to tailor the content to your interests or help us to avoid asking for the same information on repeat visits to the site. With most Internet browsers, you can erase the information, referred to as “cookies,” from your computer's hard drive, block all cookies, or even receive a warning before a cookie is placed on your system. Refer to your browser instructions or help button to learn more about cookies.
We are very concerned about protecting the privacy of children. We do not intend to collect any personally identifiable information from children under 18 years old. If a child has provided us with personally identifiable information, the parent or guardian of that child should contact us at the telephone number below if he or she wants this information deleted from our files.
If you have any questions, comments, or concerns about Bristol-Myers Squibb Sanofi-Synthelabo Partnership’s data privacy policy, please call 1-888-786-8637. Also, if you think we may have received information about you inadvertently, or if you wish to delete your personal information from our files, please call us at the above telephone number.
Bristol-Myers Squibb Sanofi-Synthelabo Partnership may at any time revise these terms and conditions by updating this posting. You are bound by any such revisions and should therefore periodically visit this page to review the then-current terms and conditions to which you are bound.
WARNING: USE IN PREGNANCY
When pregnancy is detected, discontinue AVAPRO or AVALIDE as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. [See
Warnings and Precautions: Fetal/Neonatal Morbidity and Mortality in the
full Prescribing Information.]